Abera Bioscience
web2Abera Bioscience is a Swedish biotechnology company developing nasal vaccines against infectiou...
About
Abera Bioscience is a Swedish biotechnology company developing nasal vaccines against infectious diseases using a modular platform based on bacterial outer membrane vesicles. Its technology is designed to present vaccine antigens and stimulate immune responses at mucosal surfaces and throughout the body. Development programs include a pneumococcal vaccine candidate preparing for clinical evaluation and an intranasal influenza vaccine undergoing preclinical research. The company investigates manufacturing approaches based on controlled fermentation and needle free administration. Abera also collaborates with research institutions and international partners on vaccine development and platform applications for additional infectious diseases.
Explore this sector
Exchange listings
Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.
Abera Bioscience profile.
Expert coverage
No published expert evaluations are available for this project yet.
Orbitrum Academy